MedDataX Logo

Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile

NCT ID: NCT01483794

Last Updated: 2011-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-11-30

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational study looking at the characteristics of patients consulting for genital warts in the first semester 2010 at the public sexual health clinic of Valparaiso, Chile. The objectives are: to have an epidemiological profile, estimating cost of the disease for the health system and the patient and analyzing possible psychosocial consequences of the condition for the patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Condylomata Acuminata

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

genital warts

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Genital warts treated

Patients that have had treatment on their genital warts

No interventions assigned to this group

Genital warts on treatment

Patients currently being treated for genital warts

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 18 years of age or older
* Having being diagnosed with genital warts
* Consulting the sexual health clinic only for genital warts
* Patients accepting to be included in the study

Exclusion Criteria

* Immunodeficiency
* HIV positive
* Having being diagnosed with cancer or pre-cancerous lesions
* Pregnancy
* Presenting a sexual transmissible infection other than genital warts.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad de Valparaiso

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carolina San Martin

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carolina San Martin, MD

Role: PRINCIPAL_INVESTIGATOR

University of Valparaiso, Chile

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sexual Health Clinic,

Valparaíso, Región de Valparaíso, Chile

Site Status

Sexual Health Clinic

Valparaíso, Región de Valparaíso, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Heraldo S Povea, MD

Role: CONTACT

Phone: +56-9-91629388

Email: [email protected]

Carolina San Martin, MD

Role: CONTACT

Phone: +56-9-92895478

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carolina San Martin, MD

Role: primary

Heraldo S Povea, MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1501

Identifier Type: OTHER

Identifier Source: secondary_id

CondValpo2011

Identifier Type: -

Identifier Source: org_study_id